Latest news
{{'Thu, 07 May 2026 07:00:00 -0400' | dateFormatUsFilter}}
Wegovy® access expanded for Medicare beneficiaries living with obesity through the Medicare GLP-1 Bridge starting July 1, 2026
Read more
{{'Wed, 06 May 2026 05:34:00 -0400' | dateFormatUsFilter}}
Financial report for the period January 1, 2026 to March 31, 2026
Read more
{{'Fri, 01 May 2026 08:04:00 -0400' | dateFormatUsFilter}}
Novo Nordisk's Ozempic® pill, the only FDA-approved oral peptide GLP-1 medication for adults with type 2 diabetes, soon to be available in the US
Read more
Latest on compounded and counterfeit products and other important information about semaglutide.